Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis [NA]
Completed clinical trial evaluating intestinal ultrasound for pouchitis and related outcomes after ileal pouch-anal anastomosis in ulcerativ…
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis [Phase 2]
Phase 2 trial results for OSE-127 versus placebo in moderate to severe active ulcerative colitis were completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: ENhanced Recovery in CHildren Undergoing Surgery [Phase 3]
Phase 3 trial results for enhanced recovery in children undergoing surgery for inflammatory bowel disease, including Crohn's disease and ulc…
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
A phase 2 placebo-controlled trial of brazikumab in moderately to severely active ulcerative colitis was terminated; results were posted aft…
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: Open-label Extension Study of Brazikumab in Ulcerative Colitis [Phase 2]
Open-label extension study results for brazikumab in ulcerative colitis (Phase 2) have been terminated with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating oral NX-13 for moderate to severe ulcerative colitis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: GI Permeability Change in Response to Aquamin® [Phase 2]
Phase 2 trial assessing GI permeability changes in response to Aquamin® in Ulcerative Colitis; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Long-term Extension Study of Ustekinumab in Pediatric Participants [Phase 3]
Long-term extension study of ustekinumab in pediatric participants (Phase 3) for Crohn disease, ulcerative colitis, and related psoriatic ar…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 pediatric study evaluating guselkumab in moderately to severely active ulcerative colitis is active not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis [Phase 3]
Phase 3 pediatric trial update for mirikizumab in moderately to severely active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab [Phase 3]
Phase 3 trial assessing change in disease activity in adults with moderate-to-severe Ulcerative Colitis treated with risankizumab versus ved…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating oral tofacitinib in children aged 2 to 17 with moderate to severe ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update on ABX464 assessing long-term safety and efficacy in moderate to severe active ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 3]
An extension study for treatment of moderately to severely active ulcerative colitis in Phase 3 is ongoing (ACTIVE_NOT_RECRUITING).
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis [Phase 2]
Phase 2 dose-finding trial update for SAR443122 in adults with ulcerative colitis (inactive/not recruiting).
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 3]
An extension Phase 3 clinical trial for treatment of moderately to severely active ulcerative colitis is ongoing (Extension Study).
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety [Phase 4]
Phase 4 trial evaluating efficacy and safety of an interleukin-23 monoclonal antibody for inflammatory bowel disease is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update describing a study of long-acting antibodies, alone and in combinations, for moderate to severe ulcerative col…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC [NA]
A completed trial update evaluating the efficacy and mechanism of fecal microbiota transplantation for ulcerative colitis in Bai ethnicity p…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis
This completed clinical trial evaluated physical fitness levels in children and adolescents with chronic inflammatory bowel disease, includi…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe [NA]
Massachusetts General Hospital reports an ongoing clinical trial using a colonoscope-compatible thermal probe to measure gut temperature in …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) [Phase 3]
This clinical trial update describes the Phase 3 LUCENT 3 study evaluating the long-term efficacy and safety of mirikizumab in participants …
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2) [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of IPG11406 in moderately to severely active ulcerative colitis. The study st…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC) [Phase 1, Phase 2]
The Cleveland Clinic-sponsored study evaluating mesenchymal stem cells for medically refractory ulcerative colitis in phase 1/2 has been ter…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
This Phase 2 clinical trial update reports completion of the study of JNJ-77242113 in participants with moderately to severely active ulcera…